• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diagnostic tests to mitigate the antimicrobial resistance pandemic-Still the problem child.

作者信息

Ferreyra Cecilia, Gleeson Birgitta, Kapona Otridah, Mendelson Marc

机构信息

FIND, Geneva, Switzerland.

Zambia National Public Health Institute, Lusaka, Zambia.

出版信息

PLOS Glob Public Health. 2022 Jun 30;2(6):e0000710. doi: 10.1371/journal.pgph.0000710. eCollection 2022.

DOI:10.1371/journal.pgph.0000710
PMID:36962471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10022379/
Abstract
摘要

相似文献

1
Diagnostic tests to mitigate the antimicrobial resistance pandemic-Still the problem child.缓解抗菌药物耐药性大流行的诊断测试——仍然是个难题。
PLOS Glob Public Health. 2022 Jun 30;2(6):e0000710. doi: 10.1371/journal.pgph.0000710. eCollection 2022.
2
COVID-19 pandemic and antimicrobial resistance in developing countries.发展中国家的新冠疫情与抗菌药物耐药性
Discoveries (Craiova). 2021 Jun 30;9(2):e127. doi: 10.15190/d.2021.6. eCollection 2021 Apr-Jun.
3
Antimicrobial Resistance: The Next Probable Pandemic.抗微生物药物耐药性：下一个可能大流行的疾病。
JNMA J Nepal Med Assoc. 2022 Feb 15;60(246):225-228. doi: 10.31729/jnma.7174.
4
Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics.新冠疫情期间的多药耐药危机：抗菌肽作为下一代治疗药物的作用。
Colloids Surf B Biointerfaces. 2022 Mar;211:112303. doi: 10.1016/j.colsurfb.2021.112303. Epub 2021 Dec 20.
5
Operational challenges of the Philippine Antimicrobial Resistance Surveillance Program during the COVID-19 pandemic.菲律宾在 COVID-19 大流行期间抗生素耐药性监测计划的实施挑战。
Western Pac Surveill Response J. 2022 Aug 25;13(3):1-6. doi: 10.5365/wpsar.2022.13.3.917. eCollection 2022 Jul-Sep.
6
Challenges to Antimicrobial Stewardship in the Countries of the Arab League: Concerns of Worsening Resistance during the COVID-19 Pandemic and Proposed Solutions.阿拉伯联盟国家抗菌药物管理面临的挑战：对新冠疫情期间耐药性恶化的担忧及建议解决方案
Antibiotics (Basel). 2021 Oct 29;10(11):1320. doi: 10.3390/antibiotics10111320.
7
Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks.新冠疫情对抗菌药物耐药性出现的影响：调整对未来疫情的应对措施。
Life (Basel). 2021 Mar 10;11(3):220. doi: 10.3390/life11030220.
8
Antimicrobial resistance: new insights and therapeutic implications.抗菌药物耐药性：新的认识与治疗意义。
Appl Microbiol Biotechnol. 2022 Oct;106(19-20):6427-6440. doi: 10.1007/s00253-022-12175-8. Epub 2022 Sep 19.
9
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.大流行后世界的抗菌药物耐药性研究：关于新冠疫情中抗菌药物耐药性研究的见解
J Glob Antimicrob Resist. 2021 Jun;25:5-7. doi: 10.1016/j.jgar.2021.02.013. Epub 2021 Mar 1.
10
Flare of the silent pandemic in the era of the COVID-19 pandemic: Obstacles and opportunities.新冠疫情时代隐匿性大流行的爆发：障碍与机遇
World J Clin Cases. 2023 Feb 26;11(6):1267-1274. doi: 10.12998/wjcc.v11.i6.1267.

引用本文的文献

1
A novel machine-learning aided platform for rapid detection of urine ESBLs and carbapenemases: URECA-LAMP.一种新型机器学习辅助的尿液 ESBLs 和碳青霉烯酶快速检测平台：URECA-LAMP。
J Clin Microbiol. 2024 Nov 13;62(11):e0086924. doi: 10.1128/jcm.00869-24. Epub 2024 Oct 24.
2
New Agents Are Coming, and So Is the Resistance.新的病原体正在出现，耐药性问题也随之而来。
Antibiotics (Basel). 2024 Jul 13;13(7):648. doi: 10.3390/antibiotics13070648.
3
Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review.即时检测诊断耐多药的成本效益：系统评价。
J Antimicrob Chemother. 2024 Jun 3;79(6):1248-1269. doi: 10.1093/jac/dkae067.
4
Novel lateral flow assay for point-of-care detection of Neisseria gonorrhoeae infection in syndromic management settings: a cross-sectional performance evaluation.新型侧向流动检测法在症状管理环境中即时检测淋病奈瑟菌感染的应用：一项横断面性能评估。
Lancet. 2024 Feb 17;403(10427):657-664. doi: 10.1016/S0140-6736(23)02240-7. Epub 2024 Feb 6.

本文引用的文献

1
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担：系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
2
C-reactive protein as an early biomarker for malaria infection and monitoring of malaria severity: a meta-analysis.C 反应蛋白作为疟疾感染的早期生物标志物及其对疟疾严重程度的监测：一项荟萃分析。
Sci Rep. 2021 Nov 11;11(1):22033. doi: 10.1038/s41598-021-01556-0.
3
The role of C-reactive protein in predicting the severity of COVID-19 disease: A systematic review.C反应蛋白在预测新型冠状病毒肺炎疾病严重程度中的作用：一项系统综述
SAGE Open Med. 2021 Oct 11;9:20503121211050755. doi: 10.1177/20503121211050755. eCollection 2021.
4
The Lancet Commission on diagnostics: transforming access to diagnostics.柳叶刀诊断委员会：改善诊断服务可及性
Lancet. 2021 Nov 27;398(10315):1997-2050. doi: 10.1016/S0140-6736(21)00673-5. Epub 2021 Oct 6.
5
Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.印度 COVID-19 疫情期间抗生素和羟氯喹的销售情况：一项中断时间序列分析。
PLoS Med. 2021 Jul 1;18(7):e1003682. doi: 10.1371/journal.pmed.1003682. eCollection 2021 Jul.
6
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.在国际严重急性呼吸系统与传染病联盟-世界卫生组织合作中心英国队列研究中，对首次大流行浪潮期间因 COVID-19 住院的患者中的合并感染、继发感染和抗菌药物使用情况进行的一项多中心、前瞻性队列研究。
Lancet Microbe. 2021 Aug;2(8):e354-e365. doi: 10.1016/S2666-5247(21)00090-2. Epub 2021 Jun 2.
7
Role of C- reactive proteins and liver function tests in assessing the severity of dengue fever.C 反应蛋白和肝功能试验在评估登革热严重程度中的作用。
J Pak Med Assoc. 2021 Mar;71(3):810-815. doi: 10.47391/JPMA.170.
8
Enhanced antibiotic resistance as a collateral COVID-19 pandemic effect?抗生素耐药性增强是新冠疫情的附带影响？
J Hosp Infect. 2021 Jan;107:114-115. doi: 10.1016/j.jhin.2020.11.010. Epub 2020 Nov 17.
9
Procalcitonin levels in COVID-19 patients.COVID-19 患者降钙素原水平。
Int J Antimicrob Agents. 2020 Aug;56(2):106051. doi: 10.1016/j.ijantimicag.2020.106051. Epub 2020 Jun 10.
10
Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?新型冠状病毒肺炎、合并感染与抗菌药物研发：我们有何期待？
Clin Infect Dis. 2020 Dec 17;71(10):2736-2743. doi: 10.1093/cid/ciaa524.